Detalus Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.73M | Buy |
14,701
+2
| +0% | +$371 | 0.79% | 28 |
|
|
2025
Q1 | $3.08M | Buy |
14,699
+65
| +0.4% | +$13.6K | 0.97% | 25 |
|
|
2024
Q4 | $2.6M | Buy |
14,634
+36
| +0.2% | +$6.4K | 0.86% | 25 |
|
|
2024
Q3 | $2.88M | Buy |
14,598
+44
| +0.3% | +$8.69K | 0.96% | 21 |
|
|
2024
Q2 | $2.5M | Sell |
14,554
-1,451
| -9% | -$249K | 0.86% | 22 |
|
|
2024
Q1 | $2.91M | Sell |
16,005
-124
| -0.8% | -$22.6K | 1.04% | 22 |
|
|
2023
Q4 | $2.5M | Sell |
16,129
-400
| -2% | -$62K | 1% | 21 |
|
|
2023
Q3 | $2.46M | Sell |
16,529
-200
| -1% | -$29.8K | 1.15% | 17 |
|
|
2023
Q2 | $2.25M | Buy |
16,729
+224
| +1% | +$30.2K | 1.01% | 19 |
|
|
2023
Q1 | $2.63M | Sell |
16,505
-994
| -6% | -$158K | 1.26% | 17 |
|
|
2022
Q4 | $2.83M | Buy |
17,499
+13,785
| +371% | +$2.23M | 1.38% | 16 |
|
|
2022
Q3 | $498K | Sell |
3,714
-100
| -3% | -$13.4K | 0.3% | 66 |
|
|
2022
Q2 | $584K | Hold |
3,814
| – | – | 0.34% | 56 |
|
|
2022
Q1 | $618K | Sell |
3,814
-2,400
| -39% | -$389K | 0.33% | 52 |
|
|
2021
Q4 | $841K | Sell |
6,214
-90
| -1% | -$12.2K | 0.4% | 41 |
|
|
2021
Q3 | $680K | Buy |
6,304
+350
| +6% | +$37.8K | 0.35% | 50 |
|
|
2021
Q2 | $671K | Buy |
+5,954
| New | +$671K | 0.36% | 50 |
|
|
2020
Q3 | – | Sell |
-2,474
| Closed | -$243K | – | 90 |
|
|
2020
Q2 | $243K | Buy |
+2,474
| New | +$243K | 0.19% | 80 |
|
|
2020
Q1 | – | Sell |
-2,425
| Closed | -$215K | – | 87 |
|
|
2019
Q4 | $215K | Buy |
+2,425
| New | +$215K | 0.16% | 93 |
|